Trials & Outcomes
HeartMate 3™ Clinical Trial
The MOMENTUM 3 trial is a prospective, multi-center, unblinded randomized study comparing the HeartMate 3 Left Ventricular Assist System (LVAS) to the HeartMate II LVAS in advanced stage heart failure patients.
HeartMate II Clinical Trial Results
As Thoratec's first-line intermediate-to-chronic left ventricular assist device, the HeartMate II is the most widely used, extensively studied LVAD in the world as Bridge-to-Transplantation and Destination Therapy (i.e. for patient ineligible for cardiac transplant) for advanced heart failure.
The SHIELD II Trial is a prospective, randomized, multi-center, open-label study evaluating the safety and effectiveness of HeartMate PHP™ (Percutaneous Heart Pump) in patients undergoing high-risk percutaneous coronary intervention.